| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
459 |
433 |
$39K |
| 87631 |
|
122 |
116 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
141 |
130 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
381 |
351 |
$1K |
| 80061 |
Lipid panel |
145 |
133 |
$577.25 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
12 |
12 |
$570.60 |
| 80053 |
Comprehensive metabolic panel |
75 |
71 |
$420.16 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
135 |
119 |
$272.86 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
71 |
61 |
$195.84 |
| 83655 |
|
12 |
12 |
$145.32 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
29 |
29 |
$135.94 |
| 81001 |
|
108 |
97 |
$58.00 |
| 81003 |
|
13 |
13 |
$24.75 |
| 36415 |
Collection of venous blood by venipuncture |
86 |
75 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
40 |
39 |
$0.00 |
| 82947 |
|
14 |
13 |
$0.00 |
| 81025 |
|
14 |
12 |
$0.00 |